| (Values in U.S. Thousands) | Apr, 2018 | Jan, 2018 | Oct, 2017 | Jul, 2017 | Apr, 2017 |
| Sales | -9,999,000 | -9,999,000 | -9,999,000 | -9,999,000 | -9,999,000 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -9,999,000 | -9,999,000 | -9,999,000 | -9,999,000 | -9,999,000 |
| Net Income Growth | unch | unch | unch | unch | unch |
Cdex Inc Cl A (CDEX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
CDEX Inc. develops manufactures and distributes chemical detection technologies to the healthcare, safety and security markets. The ValiMed product line provides life-saving validation of high-risk medications and pharmacy returned narcotics. The ID2 product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX Inc. is based in Tucson, Arizona.
Fiscal Year End Date: 10/31